Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 339

1.

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

Tolis G, Ackman D, Stellos A, Mehta A, Labrie F, Fazekas AT, Comaru-Schally AM, Schally AV.

Proc Natl Acad Sci U S A. 1982 Mar;79(5):1658-62.

2.

Phase II trial with D-Trp-6-LH-RH in prostatic carcinoma: comparison with other hormonal agents.

Mathé G, Schally AV, Comaru-Schally AM, Mauvernay RY, Vovan ML, Machover D, Misset JL, Court B, Bouchard P, Duchier J, et al.

Prostate. 1986;9(4):327-42.

PMID:
2947053
3.

Inhibition of the pituitary-gonadal axis by a single intramuscular administration of D-Trp-6-LH-RH (decapeptyl) in a sustained-release formulation in patients with prostatic carcinoma.

Gonzalez-Barcena D, Perez-Sanchez PL, Graef A, Gomez AM, Berea H, Comaru-Schally AM, Schally AV.

Prostate. 1989;14(4):291-300.

PMID:
2526325
4.

Long-term results with a long-acting formulation of D-TRP-6 LH-RH in patients with prostate cancer: an Italian prostatic cancer project (P.O.N.CA.P.) study.

Boccardo F, Decensi A, Guarneri D, Rubagotti A, Massa T, Martorana G, Giberti C, Cerruti GB, Tani F, Zanollo A, et al.

Prostate. 1987;11(3):243-55.

PMID:
2960957
5.

Persistent blockade of the pituitary-gonadal axis in patients with prostatic carcinoma during chronic administration of D-Trp-6-LH-RH.

Gonzalez-Barcena D, Perez-Sanchez P, Berea-Dominguez H, Graef-Sanchez A, Becerril-Morales M, Comaru-Schally AM, Schally AV.

Prostate. 1986;9(2):207-15.

PMID:
2944084
8.

[Treatment of prostatic cancer with an LH-RH agonist: the D Trp6 LH-RH. Preliminary results in 30 cases].

Steg A, Chiche R, Boccon-Gibod L, Debré B, Duchier J, Schally AV.

Ann Urol (Paris). 1984 Dec;18(6):388-92. French.

PMID:
6241820
9.

Inhibition of prostate tumors by agonistic and antagonistic analogs of LH-RH.

Schally AV, Redding TW, Comaru-Schally AM.

Prostate. 1983;4(6):545-52.

PMID:
6226942
10.

Treatment of prostatic cancer with a depot form of a luteinizing hormone-releasing hormone analogue.

Giuliani L, Barreca T, Giberti C, Franceschini R, Martorana G, Brancadoro MT, Salvemini M, Rolandi E.

Eur Urol. 1986;12(6):390-4.

PMID:
2949979
11.

[Advanced cancer of the prostate. Treatment with an LH-RH agonist, D-Trp-6-LH-RH].

Mathé G, Misset JL, Vovan ML, Machover D.

Bull Cancer. 1986;73(1):31-5. French.

PMID:
2430652
12.

Long term treatment with luteinising hormone releasing hormone agonists and maintenance of serum testosterone to castration concentrations.

Labrie F, Dupont A, Belanger A, Lachance R, Giguere M.

Br Med J (Clin Res Ed). 1985 Aug 10;291(6492):369-70.

13.

[Contribution to studies on the treatment of cancer of the prostate with D-Trp6-LH-RH].

Marcellino LR, Campanella A, Bandini M.

Biomed Pharmacother. 1987;41(9-10):468-72. French.

PMID:
2968123
15.

Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms.

Schally AV, Redding TW, Comaru-Schally AM.

Cancer Treat Rep. 1984 Jan;68(1):281-9.

PMID:
6362868
16.

Responses to the antagonistic analog of LH-RH (SB-75, Cetrorelix) in patients with benign prostatic hyperplasia and prostatic cancer.

Gonzalez-Barcena D, Vadillo-Buenfil M, Gomez-Orta F, Fuentes Garcia M, Cardenas-Cornejo I, Graef-Sanchez A, Comaru-Schally AM, Schally AV.

Prostate. 1994;24(2):84-92.

PMID:
7508623
17.

New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogen.

Labrie F, Dupont A, Belanger A, Cusan L, Lacourciere Y, Monfette G, Laberge JG, Emond JP, Fazekas AT, Raynaud JP, Husson JM.

Clin Invest Med. 1982;5(4):267-75.

PMID:
6819101
18.
19.
20.

An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer.

Chertin B, Spitz IM, Lindenberg T, Algur N, Zer T, Kuzma P, Young AJ, Catane R, Farkas A.

J Urol. 2000 Mar;163(3):838-44.

PMID:
10687989

Supplemental Content

Support Center